The US Food and Drug Administration has approved 3 different formulations of the selective dipeptidyl peptidase IV inhibitor alogliptin for the treatment of type 2 diabetes. Alogliptin is a selective ...

Discover comprehensive details about Alogliptin and Pioglitazone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...

As shown in Figure 2 and 3, the pooled SMDs for alogliptin 12.5 mg treated vs controls, and alogliptin 25 mg treated vs controls demonstrated a significant reduction in HbA1c in patients treated with ...

Takeda Pharmaceutical Co is going to have to wait a bit longer to market alogliptin after US regulators said they need more time to evaluate the Japanese drugmaker’s experimental type 2 diabetes drug.

Takeda Pharmaceutical Co has suffered a major setback after regulators in the USA rejected its type 2 diabetes therapy alogliptin and the fixed-dose combination of the drug plus the Japanese drugmaker ...

KAZANO (alogliptin/metformin HCl), NESINA (alogliptin), OSENI (alogliptin/pioglitazone) Tablets Takeda announced that the FDA has approved Nesina (alogliptin), Oseni ...

SAN FRANCISCO, June 7 /PRNewswire/ -- Results from five pivotal phase 3 studies of alogliptin were announced today at the American Diabetes Association (ADA) 68th Scientific Sessions by Takeda Global ...

Patients with Type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin ...

Get detailed information on Alogliptin and Metformin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

FDA approves 3 new diabetes treatments The FDA has approved Nesina, Oseni, and Kazano as adjuncts to diet and exercise for treating adults with type 2 diabetes. The FDA has approved three drugs with ...